Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you’ll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.
Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime’s research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions.
Research topics covered:
-------------------------
Content in this podcast is for informational or educational purposes only.
The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.
Unpacking signals emerging from claims, medical records, and patient-reported outcomes to shape the next wave of GLP-1 strategy.
Listen in and hear from industry experts who explore the evolving story of GLP-1 medications. Host Maryam Tabatabai and her guests discuss three years of GLP1 research data and examine why data is essential for clinical decision support, population health, and predictive analytics. Pat Gleason, David Lassen and Sarah Taylor address why stakeholders need to think about tackling the rising costs of weight management and GLP-1 access and why they believe sharing real-world insights is important so next generation pharmacy solutions can be built. Tune in as we reveal what the latest data shows and what’s next for GLP-1 research and innovation.
Learn more about developing a holistic GLP-1 strategy
Get the latest GLP-1 insights
Year-3 adherence and persistence data
The Skinny on GLP-1s: Part 1 | Part 2
We were in Times Square for our second annual “On-the-Road” at Specialty Summit Pharmacy Friends episode.
And this year we had a big presence in the big apple. Today, you get to hear from some of our brightest thought leaders who were there to share their insights. From the latest medical pharmacy trends to the importance of having a partner in developing a biosimilar strategy and finally what’s in the equation for creating innovative solutions to help people get their medicine plus so much more.
Tune-in and subscribe to our podcast to learn about the latest health care and pharmacy trends.
Guests include:
(00:39) Jordan Almazan, Senior Director, Clinical Strategy & Specialty Solutions
(11:40) Steve Cutts, SVP, Specialty and Clinical Solutions
(31:47) George Van Antwerp, SVP, Product Innovation
(43:07) Dinesh Kandanchatha, SVP, Chief Information and Technology Officer
(01:00:25) Roxanne Schwans, SVP, Supply Chain
(01:08:12) Brian MacDonald, Senior Director, Clinical Strategy & Programs
(01:21:41) David Root, VP, Government Affairs AND
Caitlin Berry, Senior Principal, Government Affairs Policy Advisor
In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics’ latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030.
Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk’s semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.
The Evolution of GLP-1s
www.primetherapeutics.com
All Pharmacy Friends episodes
Metabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver health
The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice
Culture isn’t just a vibe — it’s a strategy. In this Pharmacy Friends episode, Prime's Erin Feigal (CHRO) and Jeff Kaczrowski (Director of Talent Acquisition) join host Laura Spitzack to explore how culture sparks innovation, drives engagement, and delivers real business results and why ignoring the idea of culture is like ignoring gravity.
From cultural commitments to leadership styles, hear how Prime’s 7,000+ employees band together to deliver results, innovate for growth, win together and do what’s right.
Whether you're leading a team or just trying to survive the next all-hands, tune in for sharp insights and how bold ideas—from mild to wild—prove culture is the ultimate business accelerator.
Health care is constantly evolving, especially in the realm of medical pharmacy. Prime Therapeutics (Prime) has been tracking that evolution for 15 years through its annual Medical Pharmacy Trend Report, where Prime experts examine trends, analyze data and share drug forecasts to help health plans and health care leaders make the best prescribing and coverage decisions.
In the most recent episode of the Pharmacy Friends podcast, host Maryam Tabatabai, PharmD, vice president of clinical information, sat down with three leading experts — Kristen Reimers, senior vice president of specialty clinical solutions; Lisa Polakowski, director of the Medical Pharmacy Trend Report; and Ben Messerli, actuarial manager — to reflect on the history and future of this cornerstone report.
Stay tuned for the release of the Medical Pharmacy Trend Report this fall.
Want to be included in next year's research or need a printed version of of the report? Send us an email.
Follow us on our website and social channels.
https://www.primetherapeutics.com
"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.
Other ways to listen:
Amazon Music | Apple | Spotify
In this episode, you’ll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology.
Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible. Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology.
Defining precision medicine (08:50)
Evaluating real-world operational process of biomarker testing (14:36)
Turnaround times are crucial (17:40)
A patients view into the importance of time (24:39)
Technology and process aid in time and process (29:30)
Helping bridge knowledge gaps for providers and payers (33:55)
The focus is on Precision Oncology right now (37:00)
Precision medicine in other disease categories (40:09)
Future of precision oncology is bright (42:07)
References
The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.
And here we are, at the Academy of Managed Care Pharmacy Annual for a 2nd year in row for a special “on the road” episode of Pharmacy Friends.
This year, AMCP is in Houston with more than 6,000 managed care pharmacy and health care industry professionals in attendance. And thought leaders from Prime Therapeutics are also on hand to present 7 research posters and several education sessions based on our integrated medical and pharmacy claims data.
This episode will help you gain clarity on the real-world impact of GLP-1 drugs, understand how predictive modeling can help identify members enrolled in Medicare Part D at risk of large increases in prescription drug spending, and other trends shaping the health care industry.
We also have two up and coming researchers share their experience taking their first steps in the managed care space and their careers.
(00:00) Introduction
(01:05) 2024 JMCP “Article of the Year” Award for Excellence
(06:46) Latest GLP-1 research
(15:56) Accelerated Drug Approval Program
(28:00) PBM and Medical Pharmacy Industry Trends
(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering
(50:32) Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge
(55:22) Legislative Impacts on Site of Service: What is the Big Deal?
(1:00:07) The next generation of managed care professionals
Managed care pharmacy is the practice of using real-world evidence to help patients get the right medications at the right cost. At Prime Therapeutics, the dedicated researchers who use studies to identify trends and recommend programs that improve overall health outcomes are members of the elite group called the health outcomes and research teams.
Listen to explore Prime’s research room and hear from these experts about how they work so they can help Prime provide care like they would want for their loved ones.
Be sure to follow Pharmacy Friends on your favorite podcast platform and tune in on April 4 to hear from more researchers as they dive into the data they are presenting at AMCP Annual.
It’s not every day you get to listen to a conversation about health care artificial intelligence, 3D printed medicines and not so futuristic ways of simplifying not only the pharmacy experience but the entire health care industry.
George Van Antwerp, industry veteran and Prime’s new SVP of product innovation, gives you insights into how he believes changes in consumerism is one of the leading reasons why he believes the health care industry needs to evolve.
For more about George’s insights, read his Pharmacy in 2050 article published in the Journal of the American Pharmacists Association.
This episode uncovers what it’s like to investigate fraudulent pharmacies and why it matters for everyone involved.
We have an impressive guest for you today. Our host Maryam Tabatabai, talks with Prime’s special investigation unit leader Mitchell Scott and right out of the gate he describes how he wanted to broaden his horizon to help people in ways he never thought of before.
He gives you insight into how his SIU team at Prime works to protect clients, members and employees from people looking to take advantage of others through the health care system.
And that’s not it, he touches on how ALL of his team’s decisions are based on one simple thought, saving one life is all it takes for our actions to matter – and that is what they do best – providing the care they would want for their loved ones.
https://www.primetherapeutics.com
More Pharmacy Friends episodes
Prime’s Special Investigations Unit: A rockstar team
Dr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation’s health care systems seem to be much better equipped this RSV season. Finally, you’ll come away with a better understanding of what everyone can do to help prepare for this RSV season.
Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact and risk factors for all populations. Give it a listen.
CDC: RSV information
www.primethrapeutics.com
All Pharmacy Friends episodes
Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.
Millions of Americans took to voting booths to decide who will be the next president of the United States and here we are, the morning of Nov. 7, just two days after the historic election, to talk with two experts from the Prime Therapeutics government affairs team about the overall election and possible impact to our country’s health care system.
Host, Maryam Tabatabai, has a conversation with Caitlin Berry and Julie Cantor-Weinberg about the significance that these results may have in America’s history and how this election could impact the health care industry.
Our podcast
"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.
Ways to listen
Amazon Music | Apple | Spotify | YouTube
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.
Follow us on social:
https://www.linkedin.com/company/prime-therapeutics/
https://www.youtube.com/user/PrimeTherapeutics
As we close out October and American Pharmacist Month, we have a special Power of People episode of Pharmacy Friends celebrating all pharmacists.
Hear from our host Laura Spitzack and three of Prime's bright pharmacists about how they see the expanding role that a licensed pharmacist can have in addressing public health challenges. From working with technology partners to leaning into giving back to the younger generation, you will hear how they are having a hand in reshaping patient care and improving health outcomes.
Our podcast
"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.
Ways to listen
Amazon Music | Apple | Spotify
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.
Follow us on social
https://www.linkedin.com/company/prime-therapeutics/
It’s been more than 2 years since the monumental Inflation Reduction Act bill passed. The bill offers opportunity for financial relief for millions of people with Medicare by improving access to affordable treatments. And today, we’re here to talk about how Prime is positioning ourselves to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience.
Our host, Maryam Tabatabai, sits down with Prime's government programs and compliance experts Jason Moore and Angela Leroux for a conversation about the Inflation Reduction Act and why it's an important part of any government programs strategy. You’ll get a glimpse into Prime’s Center of Excellence, hear what Medicare members should be thinking about during open enrollment, and discover what health plans should expect in 2025 as the largest provisions go into effect.
More information:
https://www.primetherapeutics.com
https://www.primetherapeutics.com/medicare-and-managed-medicaid
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.
Today, we’re talking with several leaders at Prime about how each is focusing their work on the three pieces of our newly formed framework. We want to help make medications more affordable, deliver an easy, transparent experience and, most importantly, help people achieve better health.
Pt. 1 – The specialty pharmacy shift – Reimagining for success
In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.
As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.
Pt. 2 – Cell & gene therapy – The crossroads of sci-fi and reality
The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.
Pt. 3 – Health tech horizons – Diverse voices, unified innovation
In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.
In this segment, you’ll hear from Prime’s Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You’ll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey.
As a bonus, Steve also talks about how Prime’s new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.
The frontier of medicine is here, and we’re talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty.
In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You’ll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.
GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn’t nearly enough content devoted to weighing all the variables associated with them, which our experts aim to address.
In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime’s four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value.
Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University.
Developing a holistic GLP-1 strategy